KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Return on Equity: 2020-2025

Historic Return on Equity for Royalty Pharma (RPRX) over the last 6 years, with Sep 2025 value amounting to 0.14%.

  • Royalty Pharma's Return on Equity fell 4.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of 0.13% for FY2024, which is 4.00% down from last year.
  • Latest data reveals that Royalty Pharma reported Return on Equity of 0.14% as of Q3 2025, which was down 21.07% from 0.17% recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's Return on Equity ranged from a high of 0.19% in Q2 2021 and a low of 0.02% during Q4 2022.
  • Its 3-year average for Return on Equity is 0.12%, with a median of 0.13% in 2024.
  • Per our database at Business Quant, Royalty Pharma's Return on Equity dropped by 18bps in 2021 and then rose by 15bps in 2023.
  • Royalty Pharma's Return on Equity (Quarterly) stood at 0.12% in 2021, then fell by 10bps to 0.02% in 2022, then rose by 15bps to 0.17% in 2023, then dropped by 4bps to 0.13% in 2024, then declined by 4bps to 0.14% in 2025.
  • Its Return on Equity was 0.14% in Q3 2025, compared to 0.17% in Q2 2025 and 0.18% in Q1 2025.